Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Basic science, rationale, background and future of abatacept

Highly Accessed Review

The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis

Eric M Ruderman* and Richard M Pope

Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25  doi:10.1186/ar1688

Article Metrics

14096
Total accesses


4
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 108 accesses
  • Last 365 days: 725 accesses
  • All time: 14096 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Cited by

BioMed Central: 4 citations